| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mendelson Daniel Newman | Director | C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK | /s/ Daniel Mendelson | 07 Nov 2025 | 0001327897 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSBR | Option to purchase Common Stock | Award | $93,772 | +13,790 | $6.80 | 13,790 | 05 Nov 2025 | Common Stock | 13,790 | $6.80 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |